🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Connect with 4D Path @ #PMWC23 to learn about our pan-cancer diagnostic & #precisiononcology platform, & its potential to help improve the diagnostic accuracy of #cancer solely from digitized histopathology images obtained via biopsies or resections. 4dpath.com

#WorldCancerDay focuses on the importance of uniting our voices and taking action to create change and #CloseTheCareGap in the fight against #cancer. At 4D Path, we commend this effort and the pursuit to establish a future focused on better, more equitable cancer care for all!

The State of the Union Address highlighted the #CancerMoonshot goal to significantly cut the #cancer death rate. 4D Path is optimistic about the role science & technology innovation can play to support this effort for the betterment of patients worldwide. #EndCancerAsWeKnowIt

.4D Path/University of Leeds joined forces with patient advocates to author an article about the importance of public & #patientengagement in cutting-edge medical advances, including innovations in #histopathology. Read it in The Pathologist: thepathologist.com/subspecialties…. #diagnostics

.4D Path is looking forward to presenting our poster, “Automated, Ancillary Test-Free BRAF/NRAS Mutational Status Prediction from Digitized Whole Slide Images of H&E-Stained Malignant Melanomas,” @ #USCAP2023. Attend on 3/14 from 1:00-4:30 PM in Exhibit Hall B to learn more.

Visit us @ #USCAP2023 Exhibit Hall B today from 1:00-4:30 PM for our poster session, which will provide an overview of automated, ancillary test-free BRAF/NRAS mutational status prediction from digitized whole slide images of H&E-stained malignant melanomas. #DigitalPathology

ICYMI: 4D Path/University of Leeds & patient advocates authored an article in The Pathologist addressing the role of public & #patientengagement in ensuring the research/clinical adoption of new #AI & related technologies. Learn more: 4dpath.com/targeting-the-….

On #WorldHealthDay we reflect on the promise of science & technology innovation in healthcare. By supporting clinical research & new evidence-based #digitalhealth technologies, we aim to democratize & accelerate access to #precisionmedicine to empower equitable #HealthForAll.

.4D Path works with many fine laboratory professionals, including Leeds Teaching Hospitals NHS Trust Biomedical Scientist Dildar Rathore, who leverage technology to improve healthcare processes & deliver the best patient care & pathways. #MLPW23 #LabWeek2023 Leeds Teaching Hospitals

This #NWHW, we recognize the role of reliable #cancer diagnosis in improving patient outcomes. That's why we're dedicated to empowering a more accurate, efficient approach to cancer diagnosis & treatment. Together, let's continue to better #womenshealth! #NationalWomensHealthWeek

.4D Path to share new data @ NSH Meeting in collaboration with Evident Scientific & Sakura Finetek USA. Read the press release & attend our poster session this Monday, Sept. 11 @ 12:00 PM EDT @ the #2023NSHConvention to learn more. 4dpath.com/4d-path-to-sha… #NSHSC #digitalpathology

Attend our #2023NSHConvention poster session, “Automated Robust Image Analysis Qualifying H&E Staining Adequacy with Varying Hematoxylin & Eosin Incubation Times,” today @ 12:00 PM EDT to hear new data from 4D Path, Evident Scientific & Sakura Finetek USA. 4dpath.com/4d-path-to-sha…

Read 4D Path's new MedicalLab article about advances in computational #digitalpathology that hold the promise of automating H&E image-based detection & prognostic evaluation of #breastcancers. mlo-online.com/disease/cancer… #BreastCancerAwarenessMonth

.4D Path is pleased to confirm membership of UK’s Leeds Teaching Hospitals NHS Trust Innovation Pop-Up. Visit our website to learn more. 4dpath.com/4d-path-confir…

ICYMI: 4D Path recently published an article in MedicalLab examining advances in computational #digitalpathology that hold the promise of automating H&E image-based detection & prognostic evaluation of #breastcancers. Find out more on our website. 4dpath.com/advances-in-di…

Visit 4D Path’s poster session @ #SABCS23 on 12/8 from 12:00–2:00 PM CT to learn about predicting recurrence & survival in breast cancer using 4D Path’s QPOR platform. Access the agenda. sabcs.org #digitalpathology #breastcancer

Meet with 4D Path today @ the #SABCS23 Poster Session 5 from 12:00–2:00 PM CT, where we will present our work on predicting recurrence & survival in #breastcancer using 4D Path’s QPOR platform. sabcs.org #cancerdiagnostics

.4D Path recently had the honor of participating in a Friends of Friends of Cancer Research panel alongside other industry leaders to discuss the promise of #computationalpathology in #oncology #drugdevelopment & clinical care. Learn more in the white paper. friendsofcancerresearch.org/wp-content/upl…

The 4D Path team shares warm wishes for a joyous holiday season and happy New Year! In this season of gratitude, we want to extend a heartfelt thank you for being part of our journey. #HappyHolidays #HappyNewYear

We are partnering with Friends of Cancer Research on their newly launched Digital PATH Project, which will identify factors that may contribute to variability in biomarker assessment, propose areas for alignment in the field, & provide regulatory process insights. bit.ly/49f2pOu